Sempra
NYSE:SREDiversified Utilities
-$0.05 today
- Market cap
- $50.69B
- Beta
- 0.58
- P/E (TTM)
- 28.5
- EPS (TTM)
- $3.17
- Dividend yield
- 2.87%
Volume 3.38M
Average 3.74M
SRE Accounts Receivables
Cash effect of the change in amounts owed by customers; growing receivables consume cash.
SempraNYSE: SRE
Accounts Receivables · Q2 FY2026 · quarter ended Jun 2026
Accounts receivables outflow grows to $0
Q2 FY2026 accounts receivables was $0, compared with $0 a year earlier. Trailing-twelve-month accounts receivables was $0. Over 3 fiscal years it compounded at -59.3% a year.
Context
- Accounts receivables amounted to 0.5% of revenue in FY2025, down 0.4 pp from a year earlier.
- Accounts receivables increased in 1 of the last 3 fiscal years.
What to watch
Whether quarterly accounts receivables holds near $0 or moves back toward the trailing-twelve-month quarterly average of $0.
Sources:Cash FlowText generated from reported figures; not investment advice.
Accounts Receivables history
USD · from the cash flow
- Latest · FY2025
- (66M) USD
- Year-over-year change
- -155.9%
| Period | Period end | Accounts Receivables | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | (66M) | -155.9% |
| FY2024 | 2024-12-31 | 118M | -29.8% |
| FY2023 | 2023-12-31 | 168M | +117.2% |
| FY2022 | 2022-12-31 | (976M) | -62.9% |
| FY2021 | 2021-12-31 | (599M) | — |
Accounts Receivables vs competitors
How SRE compares with its peers on the latest reported figures
- SRE's LTM Jun 2026 accounts receivables of $0 is the 10th largest of the 11 companies compared; the peer median is $36.35M.
- Accounts receivables amounts to 0.0% of revenue for SRE, versus a peer median of 0.7%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Sep 2026 | $270M | -429.3% | -38.1% | 0.8% | |
| LTM Sep 2026 | $196M | -31.0% | — | 2.1% | |
| LTM Jun 2026 | $120M | -47.4% | -28.2% | 1.4% | |
| LTM Jun 2026 | $118M | -1785.7% | -19.2% | 1.2% | |
| LTM Jun 2026 | $68.7M | -73.8% | +2.5% | 0.7% | |
| LTM Jun 2026 | $31M | +155.5% | -20.2% | 1.6% | |
| LTM Jun 2026 | $22M | -38.9% | — | 0.1% | |
| LTM Jun 2026 | $6M | -60.0% | -45.6% | 0.0% | |
| LTM Sep 2026 | $4M | -98.7% | — | 0.0% | |
| LTM Jun 2026 | $0 | — | -59.3% | 0.0% | |
| LTM Jun 2026 | $0 | — | -65.4% | 0.0% | |
| Peer median (excluding SRE) | $36.35M | -60.0% | -28.2% | 0.7% | |
Competitors are the stored peer set for SRE. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Net Income | 1.46B | 2.29B | 3.62B | 3.5B | 866M |
| Depreciation & Amortization | 1.86B | 2.02B | 2.23B | 2.44B | 2.56B |
| Deferred Income Tax | (78M) | 392M | 249M | (20M) | 533M |
| Stock-Based Compensation | 63M | 71M | 80M | 86M | 0 |
| Change in Working Capital | 583M | (4.02B) | 835M | (612M) | 145M |
| Accounts Receivables | (599M) | (976M) | 168M | 118M | (66M) |
| Inventory | (87M) | (17M) | (80M) | (74M) | (64M) |
| Accounts Payables | 263M | 430M | (270M) | (131M) | (7M) |
| Other Working Capital | 1.01B | (3.46B) | 1.02B | (525M) | 282M |
| Other Non-Cash Items | (44M) | 397M | (791M) | (484M) | 458M |
| Operating Cash Flow | 3.84B | 1.14B | 6.22B | 4.91B | 4.57B |
| Capital Expenditures | (5.02B) | (5.36B) | (8.4B) | (8.22B) | (10.61B) |
| Acquisitions (Net) | 0 | 0 | 0 | 0 | 327M |
| Purchases of Investments | (1.59B) | (1.08B) | (992M) | (1.88B) | (3.05B) |
| Sales of Investments | 999M | 762M | 661M | 942M | 1.1B |
| Other Investing Activities | 102M | 632M | 12M | 32M | 23M |
| Investing Cash Flow | (5.51B) | (5.04B) | (8.72B) | (9.12B) | (12.21B) |
| Debt Repayment | 197M | 4.21B | 1.93B | 4.78B | 7.32B |
| Common Stock Issued | 5M | 4M | 145M | 1.22B | 32M |
| Common Stock Repurchased | (339M) | (478M) | (32M) | (43M) | (958M) |
| Dividends Paid | (1.43B) | (1.47B) | (1.53B) | (1.54B) | (1.64B) |
| Other Financing Activities | 2.83B | 1.52B | 2.05B | 1.01B | 4.85B |
| Financing Cash Flow | 1.26B | 3.78B | 2.42B | 5.42B | 9.6B |
| Effect of Forex Changes | 2M | (1M) | 6M | (13M) | (3.51B) |
| Net Change in Cash | (404M) | (119M) | (73M) | 1.2B | (1.56B) |
| Free Cash Flow | (1.17B) | (4.22B) | (2.18B) | (3.31B) | (6.05B) |
Sempra
NYSE:SRE
Intrinsic Alpha fair value
Locked
Current Price
$77.52
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.